Last reviewed · How we verify
flecainide iv
At a glance
| Generic name | flecainide iv |
|---|---|
| Sponsor | NYU Langone Health |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT) (PHASE3)
- Beta Blockers Plus Intravenous Flecainide for Paroxysmal Atrial Fibrillation: a Real-world Chios Registry (BETAFLEC-CHIOS)
- Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
- Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- flecainide iv CI brief — competitive landscape report
- flecainide iv updates RSS · CI watch RSS
- NYU Langone Health portfolio CI